Who is sponsoring NCT01754142?

NCT01754142 is sponsored by AstraZeneca.

What condition does NCT01754142 study?

NCT01754142 studies Diabetes Mellitus, Type 2.

What is the status of NCT01754142?

NCT01754142 is currently COMPLETED.

Last reviewed 2017-08-08 · How we verify

Korean Post-marketing Surveillance for Kombiglyze XR®

NCT01754142 COMPLETED

The purpose of this post-marketing surveillance is to investigate and confirm the type and incidence of newly identified adverse events and any other factors affecting safety and efficacy of Kombiglyze Extended release (XR) so that the regulatory authority can manage the marketing approval properly

Details

Lead sponsor	AstraZeneca
Status	COMPLETED
Enrolment	755
Start date	Sat Nov 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Sep 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Diabetes Mellitus, Type 2

Countries

South Korea